CUTANEOUS T-CELL LYMPHOMA STAGE IV

CUTANEOUS T-CELL LYMPHOMA STAGE IV was reported 36 times

CUTANEOUS T-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 3 0.0023
1 BARICITINIB 3 0.0010
2 MECHLORETHAMINE HYDROCHLORIDE 2 0.0009
3 DESLORATADINE 1 0.0001
4 BENDAMUSTINE HCL 1 0.0001
5 HUMAN IMMUNOGLOBULIN G 1 0.0000
6 UPADACITINIB 4 0.0000
7 DUPILUMAB 24 0.0000
8 HYDROXYZINE 2 0.0000
9 RABEPRAZOLE SODIUM 1 0.0000
10 BIOTIN 1 0.0000
11 IXEKIZUMAB 1 0.0000
12 EZETIMIBE 1 0.0000
13 ROSUVASTATIN 1 0.0000
14 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
15 INFLIXIMAB 2 0.0000
16 METHOTREXATE SODIUM 4 0.0000
17 RAMIPRIL 1 0.0000
18 TACROLIMUS OINTMENT 0.1% 1 0.0000
19 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
20 AMLODIPINE BESYLATE 1 0.0000
21 ALLOPURINOL 1 0.0000
22 TACROLIMUS 1 0.0000
23 DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0000
24 PREDNISOLONE ORAL SOLUTION 1 0.0000
25 RITUXIMAB 1 0.0000
26 FOLIC ACID 1 0.0000
27 PREGABALIN 1 0.0000
28 METOPROLOL TARTRATE 1 0.0000
29 LEVOTHYROXINE SODIUM 1 0.0000
30 PREDNISONE 1 0.0000